CEA, CAP-1-6-D, [Asp6] Carcinoembryonic Antigen Peptide
273€ (5 mg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
CEA, CAP-1-6-D, [Asp6] Carcinoembryonic Antigen Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx266072
Description
CEA, CAP-1-6-D, [Asp6] -Carcinoembryonic Antigen is a peptide.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | CEA, CAP-1-6-D, [Asp6] Carcinoembryonic Antigen |
| Conjugation | Unconjugated |
| Observed MW | Molecular Weight: 965.08 Da |
| Purity | > 95% (HPLC) |
| Size 1 | 5 mg |
| Size 2 | 10 mg |
| Size 3 | 25 mg |
| Form | Lyophilized |
| Buffer | Not applicable. |
| Availability | Shipped within 10-20 working days. |
| Storage | Store dry at -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Background | Protein CEA |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
Rat CEA (Carcinoembryonic Antigen) ELISA Kit
Ver Producto
Rat CEA (Carcinoembryonic Antigen) QuickTest ELISA Kit
Ver Producto
Carcinoembryonic Antigen (CEACAM5) Antibody
Carcino Embryonic Antigen (CEA) is synthesised during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
Ver Producto